• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威奥斯陆活性污泥污水处理中激素和抗生素的发生和归宿的昼夜变化。

Diurnal variations in the occurrence and the fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, Norway.

机构信息

Norwegian Institute for Water Research, NIVA, Gaustadalléen 21, Oslo, Norway.

出版信息

Sci Total Environ. 2010 Mar 15;408(8):1915-24. doi: 10.1016/j.scitotenv.2010.01.042. Epub 2010 Feb 13.

DOI:10.1016/j.scitotenv.2010.01.042
PMID:20156636
Abstract

We present an assessment of the dynamics in the influent concentration of hormones (estrone, estriol) and antibiotics (trimethoprim, sulfamethoxazole, tetracycline, ciprofloxacin) in the liquid phase including the efficiency of biological municipal wastewater treatment. The concentration of estradiol, 17-alpha-ethinylestradiol, doxycycline, oxytetracycline, demeclocycline, chlortetracycline, cefuroxime, cyclophosphamide, and ifosfamide were below the limit of detection in all of the sewage samples collected within this study. Two different types of diurnal variation pattern were identified in the influent mass loads of selected antibiotics and hormones that effectively correlate with daily drug administration patterns and with the expected maximum human hormone release, respectively. The occurrence of natural hormones and antimicrobials, administered every 12 hours, shows a daily trend of decreasing contaminant mass load, having the maximum values in the morning hours. The occurrence of antibiotics, typically administered every 8 hours, indicates a daily peak value in samples collected under the highest hydraulic loading. The efficiency of biological removal of both hormones and antibiotics is shown to be limited. Compared to the values obtained in the influent samples, increased concentrations are observed in the biologically treated effluent for trimethoprim, sulfamethoxazole and ciprofloxacin, mainly as a result of deconjugation processes. Ciprofloxacin is shown as the predominant antimicrobial compound in the effluent, and it is present at quantities approximately 10 fold greater than the total mass of the other of the compounds due to poor removal efficiency and alternating solid-liquid partitioning behaviour. Our results suggest that, to increase the micro-pollutant removal and the chemical dosing efficiency in enhanced tertiary treatment, significant benefits can be derived from the optimisation of reactor design and the development of control schemes that accounts for diurnal secondary effluent micro-pollutant and hydraulic loading patterns.

摘要

我们评估了激素(雌酮、雌三醇)和抗生素(甲氧苄啶、磺胺甲恶唑、四环素、环丙沙星)在液相中的浓度变化,包括生物市政污水处理的效率。在本研究中收集的所有污水样本中,均未检测到雌二醇、17-α-乙炔基雌二醇、强力霉素、土霉素、去甲金霉素、金霉素、头孢呋辛、环磷酰胺和异环磷酰胺的浓度。在所选择的抗生素和激素的进水质量负荷中,确定了两种不同类型的日变化模式,这两种模式分别与每日药物给药模式和预期的最大人体激素释放有效相关。天然激素和抗生素的出现,每 12 小时给药一次,显示出污染物质量负荷逐日下降的趋势,在早晨达到最大值。通常每 8 小时给药一次的抗生素,表明在水力负荷最高时采集的样本中出现了每日峰值。生物去除激素和抗生素的效率显示是有限的。与进水样本中获得的值相比,在经过生物处理的出水中,甲氧苄啶、磺胺甲恶唑和环丙沙星的浓度增加,这主要是由于去结合过程。环丙沙星是出水中主要的抗菌化合物,由于去除效率差和固液交替分配行为,其浓度约为其他化合物总质量的 10 倍。我们的研究结果表明,为了提高强化三级处理中的微污染物去除率和化学加药效率,可以从优化反应器设计和开发控制方案中获得显著的收益,该方案可以考虑到二级出水中微污染物和水力负荷的日变化模式。

相似文献

1
Diurnal variations in the occurrence and the fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, Norway.挪威奥斯陆活性污泥污水处理中激素和抗生素的发生和归宿的昼夜变化。
Sci Total Environ. 2010 Mar 15;408(8):1915-24. doi: 10.1016/j.scitotenv.2010.01.042. Epub 2010 Feb 13.
2
Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.对来自奥斯陆市两家医院和一座污水处理厂的选定人体药物进行源到汇追踪。
J Environ Monit. 2007 Dec;9(12):1410-8. doi: 10.1039/b709745j. Epub 2007 Sep 7.
3
Upflow anaerobic sludge blanket reactor--a review.上流式厌氧污泥床反应器——综述
Indian J Environ Health. 2001 Apr;43(2):1-82.
4
Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.加拿大安大略省城市污水处理厂对药品、个人护理产品及雌激素的去除情况与去除率
Sci Total Environ. 2006 Aug 31;367(2-3):544-58. doi: 10.1016/j.scitotenv.2006.03.021. Epub 2006 May 12.
5
Impacts of competitive inhibition, parent compound formation and partitioning behavior on the removal of antibiotics in municipal wastewater treatment.竞争抑制、母体化合物形成和分配行为对城市污水处理中抗生素去除的影响。
Environ Sci Technol. 2010 Jan 15;44(2):734-42. doi: 10.1021/es902264w.
6
Removal of pharmaceuticals and fragrances in biological wastewater treatment.生物废水处理中药物和香料的去除
Water Res. 2005 Sep;39(14):3139-52. doi: 10.1016/j.watres.2005.05.031.
7
Occurrence of pharmaceuticals in a municipal wastewater treatment plant: mass balance and removal processes.制药厂在城市污水处理厂的出现:质量平衡和去除过程。
Chemosphere. 2012 Jun;88(1):17-24. doi: 10.1016/j.chemosphere.2012.02.017. Epub 2012 Apr 9.
8
Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant.喹诺酮和氟喹诺酮类抗生素在城市污水处理厂中的出现和归宿。
Water Res. 2012 Feb 1;46(2):387-94. doi: 10.1016/j.watres.2011.10.055. Epub 2011 Nov 15.
9
Climate change impacts on activated sludge wastewater treatment: a case study from Norway.气候变化对活性污泥法污水处理的影响:挪威的一个案例研究
Water Sci Technol. 2009;60(2):533-41. doi: 10.2166/wst.2009.386.
10
Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.污水和污泥处理过程中药物在污水和污泥中的出现、分配和去除。
Water Res. 2011 Jan;45(3):1165-76. doi: 10.1016/j.watres.2010.11.010. Epub 2010 Nov 13.

引用本文的文献

1
Advanced Technologies for Nitrogen Removal and Recovery from Municipal and Industrial Wastewater.城市和工业废水中氮去除与回收的先进技术
Materials (Basel). 2025 Mar 23;18(7):1422. doi: 10.3390/ma18071422.
2
Snapshot Sampling May Not Be Enough to Obtain Robust Estimates for Riverine Microplastic Loads.快照采样可能不足以获得对河流微塑料负荷的可靠估计。
ACS ES T Water. 2024 Apr 12;4(5):2309-2319. doi: 10.1021/acsestwater.4c00176. eCollection 2024 May 10.
3
Short-term mass loads of per- and polyfluoroalkyl substances in a wastewater treatment plant from South China.
中国南方一家污水处理厂中全氟和多氟烷基物质的短期质量负荷。
Environ Sci Pollut Res Int. 2024 Mar;31(11):17417-17425. doi: 10.1007/s11356-024-32204-5. Epub 2024 Feb 10.
4
Diurnal changes in pathogenic and indicator virus concentrations in wastewater.污水中病原体和指示病毒浓度的昼夜变化。
Environ Sci Pollut Res Int. 2023 Dec;30(59):123785-123795. doi: 10.1007/s11356-023-30381-3. Epub 2023 Nov 22.
5
Role of Membrane-Solute Affinity Interactions in Carbamazepine Rejection and Resistance to Organic Fouling by Nano-Engineered UF/PES Membranes.膜 - 溶质亲和相互作用在纳米工程超滤/聚醚砜膜对卡马西平的截留及对有机污染抗性中的作用
Membranes (Basel). 2023 Aug 21;13(8):744. doi: 10.3390/membranes13080744.
6
Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review.废水中药品和个人护理产品的出现、转化、生物累积、风险及分析:综述
Environ Chem Lett. 2022;20(6):3883-3904. doi: 10.1007/s10311-022-01498-7. Epub 2022 Aug 17.
7
Challenges on solar oxidation as post-treatment of municipal wastewater from UASB systems: Treatment efficiency, disinfection and toxicity.太阳能氧化作为 UASB 系统处理城市污水的后处理技术:处理效率、消毒和毒性。
Sci Total Environ. 2022 Dec 1;850:157940. doi: 10.1016/j.scitotenv.2022.157940. Epub 2022 Aug 8.
8
Implementation of environmental surveillance for SARS-CoV-2 virus to support public health decisions: Opportunities and challenges.实施严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒环境监测以支持公共卫生决策:机遇与挑战。
Curr Opin Environ Sci Health. 2020 Oct;17:49-71. doi: 10.1016/j.coesh.2020.09.006. Epub 2020 Oct 1.
9
Environmental Risk and Risk of Resistance Selection Due to Antimicrobials' Occurrence in Two Polish Wastewater Treatment Plants and Receiving Surface Water.环境风险以及由于两种波兰污水处理厂和受纳地表水存在抗生素而导致的耐药性选择风险。
Molecules. 2020 Mar 24;25(6):1470. doi: 10.3390/molecules25061470.
10
Seasonal and diurnal surveillance of treated and untreated wastewater for human enteric viruses.处理和未处理废水的季节性和昼夜性人类肠道病毒监测。
Environ Sci Pollut Res Int. 2018 Nov;25(33):33391-33401. doi: 10.1007/s11356-018-3261-y. Epub 2018 Sep 27.